Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Rapiacta (peramivir) – Neuraminidase Inhibitor for Treatment of Influenza

The FDA granted EUA for the antiviral peramivir in IV formulation for the 2009 H1N1 influenza.

Go Top